HomeStock ScreenerAmanta Healthcare

Amanta Healthcare Current Share Price | Amanta Healthcare Stock Screener

AMANTA Pharmaceuticals
Live Share Price NSE
₹157.14
▲ 5.32 (3.50%)
2026-06-15 00:00:00
Live Share Price BSE
₹172.20
▲ 7.95 (4.84%)
2026-08-18 00:00:00
As of June 15, 2026, the live Amanta Healthcare share price (NSE: AMANTA) is ₹157.14 on NSE and ₹172.20 on BSE, up 3.50% from the previous close, with shares trading between ₹154.00 and ₹161.00 in today's trading session, and a 52-week range of ₹95.03–₹157.14. Analyse AMANTA price trends and track historical price performance. Use the Amanta Healthcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Amanta Healthcare Market Cap ₹668.99 Cr.
AMANTA P/E Ratio (TTM) 45.56
Amanta Healthcare P/B Ratio 3.04
EPS (TTM) ₹4.33
Dividend Yield -
Debt to Equity 2.12
AMANTA 52 Week High ₹157.14
Amanta Healthcare 52 Week Low ₹95.03
Operating Margin 20.00%
Profit Margin 5.10%
AMANTA Revenue (TTM) ₹294.00
EBITDA ₹60.00
Net Income ₹15.00
Total Assets ₹558.00
Total Equity ₹220.00

Amanta Healthcare Current Share Price Chart

Track the current Amanta Healthcare share price and stock price with an interactive chart. Analyse AMANTA price trends, trading volume, historical performance, and volatility across different timeframes — the complete Amanta Healthcare stock quote in one place.

Amanta Healthcare Company Profile - Fundamental Screener

Screen Amanta Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for AMANTA shares.
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
ISIN INE084K01015

Amanta Healthcare Balance Sheet Screener

Screen AMANTA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2026 2025 2024 2023 2022 2021 2020
Assets
Total Assets 558 382 352 374 392 392 388
Current Assets 239 138 118 131 136 131 105
Fixed Assets 289 217 228 232 240 242 244
Liabilities
Total Liabilities 0 0 0 0 0 0 0
Current Liabilities 197 170 184 214 214 262 285
Non-Current Liabilities 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 220 96 66 63 72 7 29
Share Capital 39 29 27 27 37 27 27
Reserves & Surplus 181 68 40 36 36 -20 2

Amanta Healthcare Income Statement Screener - Profit & Revenue Analysis

Screen Amanta Healthcare income statement and profit fundamentals. Analyze AMANTA quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Amanta Healthcare share price evaluation.
Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March
Revenue 294 288 276 282 263 227 172 187
Expenses 234 230 215 223 206 173 133 147
EBITDA 60 57 61 59 56 54 39 40
Operating Profit % 20.00% 20.00% 22.00% 21.00% 20.00% 23.00% 22.00% 20.00%
Depreciation 19 19 18 20 18 17 17 17
Interest 21 21 28 34 35 49 40 38
Profit Before Tax 21 21 15 5 3 62 -18 -15
Tax 7 9 4 2 5 7 4 4
Net Profit 15 13 11 4 -2 55 -22 -19
EPS 4.20 4.33 3.71 1.35 -0.79 20.54 -8.14 -7.04

Amanta Healthcare Cash Flow Screener - Liquidity Fundamentals

Screen AMANTA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March
Operating Activities 47 58 43 62 31 38
Investing Activities -25 -10 -7 -6 -13 -9
Financing Activities -24 -46 -42 -50 -18 -37
Net Cash Flow -1 1 -6 6 0 -8

Amanta Healthcare Shareholding Pattern Screener

See Amanta Healthcare shareholding pattern with promoter, FII, and DII holdings. Check Amanta Healthcare promoter holding and ownership changes for AMANTA on TickJournal.
Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Aug 2025-Jun 2025-Feb 2024-Sept
Promoter Holding 63.80% 63.72% 63.56% 63.56% 85.60% 63.56% 85.52% 85.52%
FII Holding 0.43% 0.85% 1.10% 1.00% 0.00% 2.21% 0.00% 0.00%
DII Holding 12.92% 12.88% 11.24% 11.34% 0.00% 12.22% 0.00% 0.00%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 17.45% 16.00% 16.91% 17.35% 0.00% 20.28% 0.00% 0.00%
Other Holding 5.39% 6.56% 7.19% 6.75% 14.40% 1.74% 14.48% 14.48%
Shareholder Count 12,612 15,222 16,181 360 361 30,695 200 192

Amanta Healthcare Share Dividend Screener - Share Yield Analysis

Check Amanta Healthcare dividend history with payout and yield data. View Amanta Healthcare dividend details including ex-dates and amounts for AMANTA stock.
No dividends declared by Amanta Healthcare.

Amanta Healthcare Stock Index Membership

See which indices include Amanta Healthcare stock. Check AMANTA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Amanta Healthcare is not part of any tracked indices.
Only major market indices are tracked in our system.

Amanta Healthcare Market Events Screener - Corporate Actions

Get Amanta Healthcare corporate actions including splits, bonuses, and buybacks. Check Amanta Healthcare stock events that may affect AMANTA share price.
Announcement Date Record Date Event Type Information Price Impact
2026-09-16 2026-09-16 Annual General Meeting NA -3.48%
2026-08-05 2026-08-05 Quarterly Result Announcement NA 6.95%
2026-05-19 2026-05-19 Quarterly Result Announcement NA -9.66%
2026-02-10 2026-02-10 Quarterly Result Announcement NA 1.14%
2025-11-11 2025-11-11 Quarterly Result Announcement NA -1.51%
2025-09-26 2025-09-26 Quarterly Result Announcement NA -0.50%

Amanta Healthcare Competitors Screener - Peer Comparison

Screen AMANTA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 449,899 37.16 61,674 12.69% 11,565 33.60
Divis Laboratories 227,984 78.05 11,067 13.95% 2,568 74.07
Torrent Pharmaceuticals 189,081 87.77 13,886 20.34% 2,138 54.91
Cipla 115,611 34.47 29,045 % 3,870 44.38
Zydus Life Science 112,255 24.26 27,658 17.64% 5,026 46.32
Lupin 102,054 18.33 29,039 26.75% 5,356 32.17
Dr Reddys Laboratories 98,391 30.95 35,059 3.90% 4,158 43.27
Mankind Pharma 98,293 47.74 14,636 14.85% 1,938 38.61
Laurus Labs 97,930 89.91 6,868 22.01% 890 64.93
Aurobindo Pharma 94,650 25.64 34,145 5.56% 3,503 59.26

Amanta Healthcare Company Announcements - News Screener

Screen AMANTA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-08-14 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-10 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-08-10 Announcement under Regulation 30 (LODR)-Monitoring Agency Report -
2026-08-07 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-06 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-08-05 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-08-05 Statement Of Deviation Or Variation In Utilization Of Funds If Any Under Regulation 32 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 ("SEBI Listing Regulations") -
2026-08-05 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-08-05 To Approve Unaudited Financial Results For The Quarter Ended 30Th June 2026 -
2026-08-05 Board Meeting Outcome for To Approval Unaudited Financial Results For Quarter Ended 30Th June 2026 -
2026-08-05 Announcement under Regulation 30 (LODR)-Change in Management -
2026-08-03 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-07-29 Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results For The Quarter Ended June 30 2026 -
2026-07-10 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-07-09 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-07-06 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-07-01 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-07-01 Submission Of Disclosures Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015 - Off-Market Transfer Of Equity Shares -
2026-06-29 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-06-27 Closure of Trading Window -